Những nghiên cứu mới về vắc-xin Covid-19 (Cập nhật đến ngày 26/8/2022)

Cập nhật vào: Thứ năm - 25/08/2022 13:01 Cỡ chữ Nhỏ Lớn

Không chủ quan với COVID-19, số ca nhiễm đang có xu hướng tăng. Sự xuất hiện của các biến thể phụ mới như: BA.4, BA.5, BA.2.12.1 và mới nhất là BA.2.74 của chủng Omicron đã làm số ca mắc COVID-19 gia tăng nhanh trên toàn cầu. Tại Việt Nam cũng đã ghi nhận các biến thể phụ này và số ca nhiễm đang có xu hướng gia tăng trở lại.

Để hiểu rõ hơn Cục Thông tin khoa học và công nghệ quốc gia xin giới thiệu một số bài nghiên cứu đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống.

1. Sciencedirect

1. Engineered extracellular vesicles directed to the spike protein inhibit SARS-CoV-2
Molecular Therapy - Methods & Clinical Development, Available online 2 February 2022 In press, journal pre-proof
Tristan A. Scott, Aroon Supramaniam, Kevin V. Morris
https://www.sciencedirect.com/science/article/pii/S232905012200016X/pdfft?md5=78b87fa0bcbbaba580aec97ce68a32bb&pid=1-s2.0-S232905012200016X-main.pdf

2. Immunogenicity of the ChAdOx1 nCoV-19 vaccine against SARS-CoV-2 with 12-dose vials: An interim analysis
Vaccine, 22 December 2021, Volume 40, Issue 4 (Cover date: 28 January 2022), Pages 587-593
Anan Manomaipiboon, Uraporn Phumisantiphong, Thananda Trakarnvanich
https://www.sciencedirect.com/science/article/pii/S0264410X21016327/pdfft?md5=5a138c9ce9b57e0ccc91d231886d617d&pid=1-s2.0-S0264410X21016327-main.pdf
3. Zinc associated nanomaterials and their intervention in emerging respiratory viruses: Journey to the field of biomedicine and biomaterials
Coordination Chemistry Reviews, 25 January 2022, Volume 457 (Cover date: 15 April 2022), Article 214402
Citlaly Gutiérrez Rodelo, Rafael A. Salinas, Ateet Dutt
https://www.sciencedirect.com/science/article/pii/S0010854521006767/pdfft?md5=a3755ef0f5bf7f9f8c4d665828a5944b&pid=1-s2.0-S0010854521006767-main.pdf
4. Oral subunit SARS-CoV-2 vaccine induces systemic neutralizing IgG, IgA and cellular immune responses and can boost neutralizing antibody responses primed by an injected vaccine
Vaccine, 19 January 2022, Volume 40, Issue 8 (Cover date: 16 February 2022), Pages 1098-1107
Jacob Pitcovski, Nady Gruzdev, Ehud Shahar
https://www.sciencedirect.com/science/article/pii/S0264410X22000500/pdfft?md5=caebcb1b6297c33dd2e9c3f6e3007d03&pid=1-s2.0-S0264410X22000500-main.pdf
5. Evaluation of the Gam-COVID-Vac and vaccine-induced neutralizing response against SARS-CoV-2 lineage P.1 variant in an Argentinean cohort
Vaccine, 20 December 2021, Volume 40, Issue 5 (Cover date: 31 January 2022), Pages 811-818
Sebastián Blanco, Brenda Salomé Konigheim, Sandra Verónica
https://www.sciencedirect.com/science/article/pii/S0264410X21016340/pdfft?md5=f7f35277f0d905b4cba177ac9c121259&pid=1-s2.0-S0264410X21016340-main.pdf
6. Highly feasible immunoprotective multicistronic SARS-CoV-2 vaccine candidate blending novel eukaryotic expression and Salmonella bactofection
Journal of Advanced Research, 22 July 2021, Volume 36 (Cover date: February 2022), Pages 211-222
Vijayakumar Jawalagatti, Perumalraja Kirthika, John Hwa Lee
https://www.sciencedirect.com/science/article/pii/S2090123221001417/pdfft?md5=eb8c8c9222c6821dc876eb30beef19d1&pid=1-s2.0-S2090123221001417-main.pdf
7. Changes in infectivity, severity and vaccine effectiveness against delta COVID-19 variant ten months into the vaccination program: The Israeli case
Preventive Medicine, 17 November 2021 ,Volume 154 (Cover date: January 2022), Article 106890
Mor Saban, Vicki Myers, Rachel Wilf-Miron
https://www.sciencedirect.com/science/article/pii/S0091743521004631/pdfft?md5=86be23907a1169e9b05113116febfff6&pid=1-s2.0-S0091743521004631-main.pdf
8. Vaccine efficacy against severe COVID-19 in relation to delta variant (B.1.617.2) and time since second dose in patients in Scotland (REACT-SCOT): a case-control study
The Lancet Respiratory Medicine, Available online 25 February 2022, In press, corrected proof
Paul M McKeigue, David A McAllister, Helen M Colhoun
https://www.sciencedirect.com/science/article/pii/S2213260022000455/pdfft?md5=0879a789fe5fe944a329e8e64ec23c6e&pid=1-s2.0-S2213260022000455-main.pdf
9. Protection from SARS-CoV-2 Delta one year after mRNA-1273 vaccination in rhesus macaques coincides with anamnestic antibody response in the lung
Cell3 December 2021, Volume 185, Issue 1 (Cover date: 6 January 2022), Pages 113-130.e15
Matthew Gagne, Kizzmekia S. Corbett, Robert A. Seder
https://www.sciencedirect.com/science/article/pii/S0092867421014057/pdfft?md5=5028a84a4e8ef12055336ba96882be3c&pid=1-s2.0-S0092867421014057-main.pdf
10. SARS-CoV-2 breakthrough infections elicit potent, broad, and durable neutralizing antibody responses
Cell, 20 January 2022, Volume 185, Issue 5 (Cover date: 3 March 2022), Pages 872-880.e3
Alexandra C. Walls, Kaitlin R. Sprouse, David Veesler
https://www.sciencedirect.com/science/article/pii/S0092867422000691/pdfft?md5=da7ae19187844c1b4a6abcffadd99373&pid=1-s2.0-S0092867422000691-main.pdf
11. Real-world effectiveness of the mRNA-1273 vaccine against COVID-19: Interim results from a prospective observational cohort study
The Lancet Regional Health - Americas, 25 November 2021, Volume 6 (Cover date: February 2022), Article 100134
Katia J. Bruxvoort, Lina S. Sy, Hung Fu Tseng
https://www.sciencedirect.com/science/article/pii/S2667193X21001307/pdfft?md5=04f1b7a21a4375a005eaa321dd76d3f1&pid=1-s2.0-S2667193X21001307-main.pdf
12. Towards a population-based threshold of protection for COVID-19 vaccines
Vaccine, 15 December 2021, Volume 40, Issue 2 (Cover date: 21 January 2022), Pages 306-315
David Goldblatt, Andrew Fiore-Gartland, Donna Ambrosino
https://www.sciencedirect.com/science/article/pii/S0264410X21016157/pdfft?md5=9d4a8421936835b7e0d07a5b208cb4cd&pid=1-s2.0-S0264410X21016157-main.pdf
13. Assessment of BIV1-CovIran inactivated vaccine-elicited neutralizing antibody against the emerging SARS-CoV-2 variants of concern
Clinical Microbiology and Infection, Available online 3 March 2022, In press, journal pre-proof
Mohammadreza Salehi, Hamed Hosseini, Asghar Abdoli
https://www.sciencedirect.com/science/article/pii/S1198743X22001070/pdfft?md5=e0f62b3684057a2075824f557f9739a2&pid=1-s2.0-S1198743X22001070-main.pdf
14. Reactogenicity and immunogenicity of heterologous prime-boost immunization with COVID-19 vaccine
Biomedicine & Pharmacotherapy, 19 January 2022, Volume 147 (Cover date: March 2022), Article 112650
Thuy Trang Nguyen, Trang Ho Thu Quach, Giau Van Vo
https://www.sciencedirect.com/science/article/pii/S0753332222000385/pdfft?md5=47c7f5527fb1031fd4922cc1a9a7adde&pid=1-s2.0-S0753332222000385-main.pdf
15. SARS-CoV-2 variant surge and vaccine breakthrough infection: A computational analysis
Informatics in Medicine Unlocked, 4 February 2022, Volume 29 (Cover date: 2022), Article 100873
Ibrahim Khater, Aaya Nassar
https://www.sciencedirect.com/science/article/pii/S2352914822000272/pdfft?md5=3056f8f098cae4e5395339322534b9e8&pid=1-s2.0-S2352914822000272-main.pdf
16. Bacteria-enabled oral delivery of a replicon-based mRNA vaccine candidate protects against ancestral and delta variant SARS-CoV-2
Molecular Therapy, Available online 3 February 2022, In press, corrected proof
Vijayakumar Jawalagatti, Perumalraja Kirthika, John Hwa Lee
https://www.sciencedirect.com/science/article/pii/S1525001622000818/pdfft?md5=0c1bb6fd10c6c9a6379e2b0ee1449d9e&pid=1-s2.0-S1525001622000818-main.pdf
17. Immunogenicity of a third dose viral-vectored COVID-19 vaccine after receiving two-dose inactivated vaccines in healthy adults
Vaccine, 3 December 2021, Volume 40, Issue 3 (Cover date: 24 January 2022), Pages 524-530
Ritthideach Yorsaeng, Nungruthai Suntronwong, Yong Poovorawan
https://www.sciencedirect.com/science/article/pii/S0264410X21015607/pdfft?md5=72a2fd9f79646c4b062bef85514d8f8d&pid=1-s2.0-S0264410X21015607-main.pdf
18. Effectiveness estimates of three COVID-19 vaccines based on observational data from Puerto Rico
The Lancet Regional Health - Americas, 24 February 2022, Volume 9 (Cover date: May 2022), Article 100212
Mónica M. Robles-Fontán, Elvis G. Nieves, Rafael A. Irizarry
https://www.sciencedirect.com/science/article/pii/S2667193X22000291/pdfft?md5=49fa064edfb3d7139cad72b99dec765e&pid=1-s2.0-S2667193X22000291-main.pdf

19. Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression
The Lancet, 23 February 2022, Volume 399, Issue 10328 (Cover date: 5–11 March 2022), Pages 924-944
Daniel R Feikin, Melissa M Higdon, Minal K Patel
https://www.sciencedirect.com/science/article/pii/S0140673622001520/pdfft?md5=73298251fb995c65daab64f1dfeeae29&pid=1-s2.0-S0140673622001520-main.pdf
20. Human inhalable antibody fragments neutralizing SARS-CoV-2 variants for COVID-19 therapy
Molecular Therapy, Available online 12 February 2022 In press, corrected proof
Olga Minenkova, Daniela Santapaola, Rita De Santis
https://www.sciencedirect.com/science/article/pii/S152500162200096X/pdfft?md5=90a28a2d139af2796942c28fea92c021&pid=1-s2.0-S152500162200096X-main.pdf
21. Kappa-RBD produced by glycoengineered Pichia pastoris elicited high neutralizing antibody titers against pseudoviruses of SARS-CoV-2 variants
Virology, Available online 6 March 2022 In press, journal pre-proof
Taotao Mi, Tiantian Wang, Bo Liu
https://www.sciencedirect.com/science/article/pii/S004268222200037X/pdfft?md5=645299c40afd1c31b131f8fc14e451c6&pid=1-s2.0-S004268222200037X-main.pdf
22. Effectiveness of an inactivated virus-based SARS-CoV-2 vaccine, BBV152, in India: a test-negative, case-control study
The Lancet Infectious Diseases, 23 November 2021, Volume 22, Issue 3 (Cover date: March 2022), Pages 349-356
Devashish Desai, Adil Rashid Khan, Randeep Guleria
https://www.sciencedirect.com/science/article/pii/S1473309921006745/pdfft?md5=15321076d16765d849379e1ad75ecde4&pid=1-s2.0-S1473309921006745-main.pdf
23. Comparison of Moderna versus Pfizer-BioNTech COVID-19 vaccine outcomes: A target trial emulation study in the U.S. Veterans Affairs healthcare system
eClinicalMedicine, 5 March 2022, Volume 45 (Cover date: March 2022), Article 101326
George N. Ioannou, Emily R. Locke, Kristin Berry
https://www.sciencedirect.com/science/article/pii/S2589537022000566/pdfft?md5=4726b15d106d4c84b6f14d02da58fd5b&pid=1-s2.0-S2589537022000566-main.pdf
24. Comparative vaccine effectiveness against severe COVID-19 over time in US hospital administrative data: a case-control study
The Lancet Respiratory Medicine Available online 25 February 2022 In press, corrected proof
Bill J Wright, Samuel Tideman, Ari Robicsek
https://www.sciencedirect.com/science/article/pii/S221326002200042X/pdfft?md5=7dcbb17c7f4e31f9a50c6112f454c297&pid=1-s2.0-S221326002200042X-main.pdf
25. Bovine-derived antibodies and camelid-derived nanobodies as biotherapeutic weapons against SARS-CoV-2 and its variants: A review article
International Journal of Surgery, 19 January 2022, Volume 98 (Cover date: February 2022), Article 106233
AbdulRahman A. Saied, Asmaa A. Metwally, Kuldeep Dhama
https://www.sciencedirect.com/science/article/pii/S1743919122000103/pdfft?md5=9c8155a3fd133ade2bfc31634f30bec4&pid=1-s2.0-S1743919122000103-main.pdf

2. Springer

1. Acceptance of COVID-19 vaccine and determinant factors in the Iranian population: a web-based study
Shabnam Omidvar, Mojgan Firouzbakht in BMC Health Services Research (2022)
https://link.springer.com/content/pdf/10.1186%2Fs12913-022-07948-w.pdf
2. Scaling up the discovery of hesitancy profiles by identifying the framing of beliefs towards vaccine confidence in Twitter discourse
Maxwell A. Weinzierl, Suellen Hopfer, Sanda M. Harabagiu in Journal of Behavioral Medicine (2022)
https://link.springer.com/content/pdf/10.1007%2Fs10865-022-00328-z.pdf
3. Evaluation of the Acceptance Rate of Covid-19 Vaccine and its Associated Factors: A Systematic Review and Meta-analysis
Mohsen Kazeminia, Zeinab Mohseni Afshar, Mojgan Rajati… in Journal of Prevention (2022)
https://link.springer.com/content/pdf/10.1007%2Fs10935-022-00684-1.pdf
4. COVID-19 Vaccine Hesitancy, Acceptance, and Promotion Among Healthcare Workers: A Mixed-Methods Analysis
Beth L. Hoffman, Cassandra L. Boness, Kar-Hai Chu… in Journal of Community Health (2022)
https://link.springer.com/content/pdf/10.1007%2Fs10900-022-01095-3.pdf
5. Coronavirus Disease 2019 (COVID-19) Vaccination for Children: Position Statement of Indian Academy of Pediatrics Advisory Committee on Vaccination and Immunization Practices
Dr Srinivas G. Kasi, Shashi Kant Dhir, Abhay Shah, S. Shivananda… in Indian Pediatrics (2022)
https://link.springer.com/content/pdf/10.1007%2Fs13312-022-2421-9.pdf
6. Humoral immunity against Covid-19 six months after the Pfizer BNT162b2 vaccine in hemodialysis patients: data from five dialysis units. Is there a protective role for hemodiafiltration in the Covid-19 pandemic?
Teresa Chuva, Teresa Santos, Francisco Gonçalves, Luísa Costa… in Journal of Nephrology (2022)
https://link.springer.com/content/pdf/10.1007%2Fs40620-022-01350-9.pdf
7. Ruxolitinib does not impair humoral immune response to COVID-19 vaccination with BNT162b2 mRNA COVID-19 vaccine in patients with myelofibrosis
Giovanni Caocci, Olga Mulas, Daniela Mantovani, Alessandro Costa… in Annals of Hematology (2022)
https://link.springer.com/content/pdf/10.1007%2Fs00277-021-04613-w.pdf
8. Trends in emergency department visits for mental health disorder diagnoses before and during the COVID-19 pandemic: a retrospective cohort study 2018–2021
Majed Ramadan, Alaa M. Fallatah, Yara F. Batwa, Ziyad Saifaddin… in BMC Psychiatry (2022)
https://link.springer.com/content/pdf/10.1186%2Fs12888-022-03988-y.pdf
9. Various vaccine platforms in the field of COVID-19
K. Savina, Rakhy Sreekumar, V. K. Soonu… in Beni-Suef University Journal of Basic and … (2022)
https://link.springer.com/content/pdf/10.1186%2Fs43088-022-00215-1.pdf
10. COVID-19 Outcomes and Vaccination in Patients with Spondyloarthritis
Atul Deodhar, Suleman Bhana, Kevin Winthrop, Lianne S. Gensler in Rheumatology and Therapy (2022)
https://link.springer.com/content/pdf/10.1007%2Fs40744-022-00462-9.pdf
11. Unilateral axillary adenopathy induced by COVID-19 vaccine: US follow-up evaluation
Alba Cristina Igual-Rouilleault, Ignacio Soriano, Paola Leonor Quan… in European Radiology (2022)
https://link.springer.com/content/pdf/10.1007%2Fs00330-021-08309-7.pdf
12. Knowledge, attitudes, and perceptions of COVID-19 vaccine and refusal to receive COVID-19 vaccine among healthcare workers in northeastern Ethiopia
Metadel Adane, Ayechew Ademas, Helmut Kloos in BMC Public Health (2022)
https://link.springer.com/content/pdf/10.1186%2Fs12889-021-12362-8.pdf
13. Optimization of FDG PET study after mRNA COVID-19 vaccination to reduce the interference of vaccine-associated hypermetabolic lymphadenopathy
Wajana Thaweerat in Annals of Nuclear Medicine (2022)
https://link.springer.com/content/pdf/10.1007%2Fs12149-021-01712-6.pdf
14. Attitudes toward a COVID-19 vaccine and vaccination status in cancer patients: correspondence
Rujittika Mungmunpuntipantip… in Journal of Cancer Research and Clinical On… (2022)
https://link.springer.com/content/pdf/10.1007%2Fs00432-022-03994-3.pdf
15. Vasculitis and bursitis on [18F]FDG-PET/CT following COVID-19 mRNA vaccine: post hoc ergo propter hoc?
Jan-Henning Schierz, Christine Merkel… in European Journal of Nuclear Medicine and M… (2022)
https://link.springer.com/content/pdf/10.1007%2Fs00259-021-05553-3.pdf